Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

VBI Is Ready To Take On HBV Vaccine Market

Jan 10 2020

• By Leah Samuel

Hepatitis B — VBI's hepatitis B vaccine faces tough competition from Dynavax.

Related Content

Dynavax's Hep B Vaccine Finally Clears US FDA With Clean Label But Larger Safety Study

Nov 13 2017

Heplisav Vaccine Postmarketing Study Might Overcome FDA Safety Worries At Panel

Jul 26 2017

VBI Looking To Market More Potent, Less Expensive Hepatitis B Vaccine

Nov 13 2019

Related Companies

VBI Vaccines Inc.

GSK plc

Dynavax Technologies Corporation

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.